Obstetrics and Gynaecology - Research Publications

Permanent URI for this collection

http://hdl.handle.net/11343/208

Filters

2020 - 2022 3
3
Reset filters

Settings
Statistics
Citations
Author: Homer, Caroline × Author: Whitehead, Clare ×

Search Results

Now showing 1 - 3 of 3
  • Item
    Thumbnail Image
    The National COVID-19 Clinical Evidence Taskforce: pregnancy and perinatal guidelines
    Homer, CSE ; Roach, V ; Cusack, L ; Giles, ML ; Whitehead, C ; Burton, W ; Downton, T ; Gleeson, G ; Gordon, A ; Hose, K ; Hunt, J ; Kitschke, J ; McDonnell, N ; Middleton, P ; Oats, JJN ; Shand, AW ; Wilton, K ; Vogel, J ; Elliott, J ; McGloughlin, S ; McDonald, SJ ; White, H ; Cheyne, S ; Turner, T (WILEY, 2022-11-06)
    INTRODUCTION: Pregnant women are at higher risk of severe illness from coronavirus disease 2019 (COVID-19) than non-pregnant women of a similar age. Early in the COVID-19 pandemic, it was clear that evidenced-based guidance was needed, and that it would need to be updated rapidly. The National COVID-19 Clinical Evidence Taskforce provided a resource to guide care for people with COVID-19, including during pregnancy. Care for pregnant and breastfeeding women and their babies was included as a priority when the Taskforce was set up, with a Pregnancy and Perinatal Care Panel convened to guide clinical practice. MAIN RECOMMENDATIONS: As of May 2022, the Taskforce has made seven specific recommendations on care for pregnant women and those who have recently given birth. This includes supporting usual practices for the mode of birth, umbilical cord clamping, skin-to-skin contact, breastfeeding, rooming-in, and using antenatal corticosteroids and magnesium sulfate as clinically indicated. There are 11 recommendations for COVID-19-specific treatments, including conditional recommendations for using remdesivir, tocilizumab and sotrovimab. Finally, there are recommendations not to use several disease-modifying treatments for the treatment of COVID-19, including hydroxychloroquine and ivermectin. The recommendations are continually updated to reflect new evidence, and the most up-to-date guidance is available online (https://covid19evidence.net.au). CHANGES IN MANAGEMENT RESULTING FROM THE GUIDELINES: The National COVID-19 Clinical Evidence Taskforce has been a critical component of the infrastructure to support Australian maternity care providers during the COVID-19 pandemic. The Taskforce has shown that a rapid living guidelines approach is feasible and acceptable.
  • Item
    Thumbnail Image
    Counting stillbirths and COVID 19-there has never been a more urgent time
    Homer, CSE ; Leisher, SH ; Aggarwal, N ; Akuze, J ; Babona, D ; Blencowe, H ; Bolgna, J ; Chawana, R ; Christou, A ; Davies-Tuck, M ; Dandona, R ; Gordijn, S ; Gordon, A ; Jan, R ; Korteweg, F ; Maswime, S ; Murphy, MM ; Quigley, P ; Storey, C ; Vallely, LM ; Waiswa, P ; Whitehead, C ; Zeitlin, J ; Flenady, V (ELSEVIER SCI LTD, 2021-01)
  • Item
    Thumbnail Image
    Clinical care of pregnant and postpartum women with COVID-19: Living recommendations from the National COVID-19 Clinical Evidence Taskforce
    Vogel, JP ; Tendal, B ; Giles, M ; Whitehead, C ; Burton, W ; Chakraborty, S ; Cheyne, S ; Downton, T ; Navarro, DF ; Gleeson, G ; Gordon, A ; Hunt, J ; Kitschke, J ; McDonald, S ; McDonnell, N ; Middleton, P ; Millard, T ; Murano, M ; Oats, J ; Tate, R ; White, H ; Elliott, J ; Roach, V ; Homer, CSE (WILEY, 2020-12)
    To date, 18 living recommendations for the clinical care of pregnant and postpartum women with COVID-19 have been issued by the National COVID-19 Clinical Evidence Taskforce. This includes recommendations on mode of birth, delayed umbilical cord clamping, skin-to-skin contact, breastfeeding, rooming-in, antenatal corticosteroids, angiotensin-converting enzyme inhibitors, disease-modifying treatments (including dexamethasone, remdesivir and hydroxychloroquine), venous thromboembolism prophylaxis and advanced respiratory support interventions (prone positioning and extracorporeal membrane oxygenation). Through continuous evidence surveillance, these living recommendations are updated in near real-time to ensure clinicians in Australia have reliable, evidence-based guidelines for clinical decision-making. Please visit https://covid19evidence.net.au/ for the latest recommendation updates.